The founder of David Protein, maker of protein-rich nutrition bars, announcement on X Monday, longevity guru Dr. Peter Attia “resigned from his role as chief scientific officer at David.”
The announcement comes after Attia’s name appeared in more than 1,700 documents, including email correspondence, released Friday as part of a massive case linked to convicted sex offender Jeffrey Epstein, according to the New York Times. Attia was part of the food startup’s management team and was also first investor.
For those who don’t know him, Attia is a Canadian-American physician who has become one of the most prominent voices in longevity and preventative health. He is best known for his bestselling book “Outlive: The Science and Art of Longevity” and his seven-year-old podcast, in which he explores optimization strategies. He was also hired last month as a CBS contributor.
Three-year-old New York-based David Protein raised a $75 million Series A funding round in May last year, led by Greenoaks, with participation from Valor Equity Partners. The company has seen significant growth since launching its flagship protein bar in September 2024, a product it describes as containing 28 grams of protein, zero sugar and 150 calories.
In a long post onAttia wrote that he was “ashamed” of some of the crude content of his emails with Epstein, but he also said that he was not involved in criminal activity and had never visited Epstein’s island or traveled on his plane. Attia also spoke at length about how he knew Epstein and why he remained involved with him even after Epstein’s death. 2008 conviction.
The consequences appear to extend beyond David Protein. It also appears that Biograph, the health and longevity testing startup that Attia co-founded with entrepreneur John Hering, may distance itself from the doctor. The company declined to comment on Attia’s continued involvement with the startup or pages on its website that previously mentioned him but now omit his name or return a “file not found” error.
The biography came out stealthily a year ago, TechCrunch has already reportedwith support from investors including Vy Capital, Human Capital, Alpha Wave and WndrCo, as well as angel investors including Balaji Srinivasan. Like a growing number of concierge medical services companies, Biograph offers premium preventive health services to subscribers who pay between $7,500 and $15,000 per year. Attia was previously named on the the company’s press release and the site as co-founder.
Techcrunch event
Boston, Massachusetts | June 23, 2026